Chapter 239 Acquired Myasthenia Gravis in Dogs and Cats
- Abelson AL et al: Use of mycophenolate mofetil as a rescue agent in the treatment of severe generalized myasthenia gravis in three dogs, J Vet Emerg Crit Care 19:369, 2009.
- Arsura E et al: High-dose intravenous methylprednisolone in myasthenia gravis, Arch Neurol 42:1149, 1985. PUBMED Abstract
- Dewey CW et al: Clinical forms of acquired myasthenia gravis in dogs: 25 cases (1988-1995), J Vet Intern Med 11:50, 1997. PUBMED Abstract
- Dewey CW et al: Mycophenolate mofetil treatment in dogs with serologically diagnosed acquired myasthenia gravis: 27 cases (1999-2000), J Am Vet Med Assoc 236:664, 2010. PUBMED Abstract
- Ducoté JM, Dewey CW, Coates JR: Clinical forms of acquired myasthenia gravis in cats, Compend Contin Educ Pract Vet 21:440, 1999.
- Foy DS et al: Cholinergic crisis after neostigmine administration in a dog with acquired focal myasthenia gravis, J Vet Emerg Crit Care 21:547, 2011. PUBMED Abstract
- Khorzad R et al: Myasthenia gravis in dogs with an emphasis on treatment and critical care management, J Vet Emerg Crit Care 21:193, 2011. PUBMED Abstract
- King LG, Vite CH: Acute fulminating myasthenia gravis in five dogs, J Am Vet Med Assoc 212:830, 1998. PUBMED Abstract
- Shelton GD: Myasthenia gravis and disorders of neuromuscular transmission, Vet Clin North Am Small Anim Pract 32:189, 2002. PUBMED Abstract
- Shelton GD et al: Acquired myasthenia gravis: selective involvement of esophageal, pharyngeal, and facial muscles, J Vet Intern Med 4:281, 1990. PUBMED Abstract
- Shelton GD, Ho M, Kass PH: Risk factors for acquired myasthenia gravis in cats: 105 cases (1986-1998), J Am Vet Med Assoc 216:55, 2000. PUBMED Abstract
- Shelton GD, Lindstrom JM: Spontaneous remission in canine myasthenia gravis: implications for assessing human MG therapies, Neurology 57:2139, 2001. PUBMED Abstract
- Shelton GD, Schule A, Kass PH: Risk factors for acquired myasthenia gravis in dogs: 1154 cases (1991-1995), J Am Vet Med Assoc 211:1428, 1997. PUBMED Abstract